Menu Toggle
Close
I'm searching for
Conferences
Training
Webinars
Information Centre
Conferences
Menu Item Arrow
Training
Menu Item Arrow
Webinars
Menu Item Arrow
Consultancy
Partner Area
About
Contact
Blog
Conferences
Menu Item Arrow
All Events Workshops & Exhibitions
Menu Item Arrow
Face-To-Face Events Workshops & Exhibitions
Menu Item Arrow
Online Events Workshops & Exhibitions
Menu Item Arrow
Exhibitions
Sponsorship
Training
Menu Item Arrow
All Courses Training Schedule
Menu Item Arrow
Face-To-Face Courses Training Schedule
Menu Item Arrow
Online Courses Training Schedule
Menu Item Arrow
In-House Training
My Library
Webinars
Menu Item Arrow
Scheduled Webinars Webinar Schedule
Menu Item Arrow
Webinars Archive Webinar Archive
Menu Item Arrow
Bespoke Webinars Specialist Courses
Menu Item Arrow

Peptide Therapeutics CMC: Impurities Management and Control Strategy

Book This Date View Other Dates
Date
30 Sep - 1 Oct 2026
  • PDT: 5.30am-9.30am
  • CDT: 7.30am-11.30am
  • EDT: 8.30am-12.30pm
  • BST: 1.30pm-5.30pm
  • CEST: 2.30pm-6.30pm
Format
Online
Duration
2 Sessions
Tutors
Dr Osama Chahrour & Dr Andrew Teasdale
I really enjoyed this course since it gave an all-round understanding of the ins and outs of peptide manufacturing and control in CMC. And especially the instructors own experience with the authorities and how to interpret the guidelines was very valuable.
Peptide Therapeutics CMC Previous attendee, Online, July 2026
This new training by Andrew Teasdale and Osama Chahrour was truly enriching with relevant topics. It is a must for chemists and CMC Leaders starting in the world of peptides.
Peptide Therapeutics CMC Previous attendee, Online, July 2026
This course is a highly recommendable summary and training for anybody who wants to deepen his/her understanding of the regulatory aspects regarding development of peptide drugs, as both as theoretical and practical issues during peptide manufacture. Held by excellent speakers.
Peptide Therapeutics CMC Previous attendee, Online, July 2026
The course was very interesting: the lecturers explained the basic concepts clearly and were kind enough to answer the many questions that were asked.
Peptide Therapeutics CMC Previous attendee, Online, July 2026

About This Date

This is the 30 September 2026 run of Peptide Therapeutics CMC: Impurities Management and Control Strategy, delivered online - live - 2 sessions.

Looking for the full syllabus, learning outcomes and tutor profiles? See the full course page →

Date Logistics

Dates 30 Sep - 1 Oct 2026
Format Online - Live - 2 Sessions
Session Times
  • PDT: 5.30am-9.30am
  • CDT: 7.30am-11.30am
  • EDT: 8.30am-12.30pm
  • BST: 1.30pm-5.30pm
  • CEST: 2.30pm-6.30pm
Tutors Dr Osama Chahrour & Dr Andrew Teasdale

Registration Fees

Category Rate
Standard £899
  • Instructor‑led lectures and case studies covering peptide CMC, impurities, and control strategies.
  • Interactive workshops and templates for risk assessment, control strategy mapping, and specification drafting.
  • Course materials: Slides, checklists, example protocols (e.g., forced degradation), and reference outlines for Module 3 sections. E-reader version included, optional printed copy available for purchase
  • Tools and examples: Sample impurity classification matrices, method validation plans, and control strategy frameworks.
  • Q&A sessions and discussion: Opportunities to address participants’ specific challenges.
  • Certificate of completion acknowledging professional development.
*VAT will be applied to companies based in the UK.
E-Reader: Included
Printed Copy: £90.00 + P&P
This short course is offered at a reduced rate, so there are no further offers available.

All fees exclude VAT. Group discounts are available: contact us for in-house delivery.

Book the 30 Sep - 1 Oct 2026

Limited places

Book Now

What Attendees Say

I really enjoyed this course since it gave an all-round understanding of the ins and outs of peptide manufacturing and control in CMC. And especially the instructors own experience with the authorities and how to interpret the guidelines was very valuable.
Peptide Therapeutics CMC Previous attendee, Online, July 2026
This new training by Andrew Teasdale and Osama Chahrour was truly enriching with relevant topics. It is a must for chemists and CMC Leaders starting in the world of peptides.
Peptide Therapeutics CMC Previous attendee, Online, July 2026
This course is a highly recommendable summary and training for anybody who wants to deepen his/her understanding of the regulatory aspects regarding development of peptide drugs, as both as theoretical and practical issues during peptide manufacture. Held by excellent speakers.
Peptide Therapeutics CMC Previous attendee, Online, July 2026
The course was very interesting: the lecturers explained the basic concepts clearly and were kind enough to answer the many questions that were asked.
Peptide Therapeutics CMC Previous attendee, Online, July 2026